Search

Your search keyword '"Mishra, Mitali"' showing total 187 results
Start Over Author "Mishra, Mitali"
187 results on '"Mishra, Mitali"'

11. SARS-CoV-2 Sequence Analysis during COVID-19 Case Surge, Liberia, 2021

Author

Shobayo, Bode, Mishra, Mitali, Sameroff, Stephen, Petrosov, Alexandra, Ng, James, Gokden, Alper, MaCauley, Jane, Jain, Komal, Renken, Courtney, Duworko, James Tanu, Badio, Moses, Jallah, Wilhemina, Hensley, Lisa, Briese, Thomas, Lipkin, W. Ian, and Mishra, Nischay

Subjects
Epidemics -- Statistics -- Causes of -- Liberia, Hospital patients -- Statistics, Health
Abstract

Before May 2021, Liberia reported 200 cases and 10-15 deaths per day in mid-July 2021 (Appendix Figure 1, https://wwwnc. cdc.gov/EID/article/27/12/21-1818-App1.pdf). To determine whether the rapid case surge was associated with [...]

Published
2021
Full Text
View/download PDF

16. Effectiveness of autologous leukocyte-platelet-rich fibrin on the rate of maxillary canine retraction, rotation, pain, and soft tissue healing: A split-mouth randomized controlled trial.

Author

Satapathy, Subrat Kumar, Das, Surya Kanta, Barik, Ashish Kumar, Mohanty, Devpartim, Rath, Sunil Kumar, and Mishra, Mitali

Subjects
CORRECTIVE orthodontics, RANDOMIZED controlled trials, DENTAL schools, LOCAL government, HEALING
Abstract

Objective: To assess the effectiveness of leukocyte-platelet-rich fibrin (L-PRF) compared with conventional treatment on canine retraction, rotation, pain, and soft tissue healing. Methods: Sixteen adult patients aged 18-25 years (10 females, and 6 males; mean age 22.25 ± 2.26 years) with Class I bimaxillary protrusion and Class II div 1 malocclusion participated in this single-center, split-mouth randomized controlled trial at the Orthodontics Department of a single hospital in SCB Dental College and Hospital, Cuttack, India. Randomization was performed using a computer-assisted function with a 1:1 allocation ratio. The intervention included the placement of L-PRF on the experimental side and follow-up for 90 days. The primary outcome measures were canine retraction, rotation, pain, and soft tissue healing. The range of tooth movement was evaluated at 15-day intervals: 0th day (T0), 15th day (T1), 30th day (T2), 45th day (T3), 60th day (T4), 75th day (T5), and 90th day (T6). Canine rotation was assessed at T0 and T6, and pain and soft tissue healing were evaluated on the 3rd, 7th, and 15th days of the treatment. Results: Cumulatively, the L-PRF group demonstrated a significantly greater tooth movement as compared to conventional treatment group (P < 0.001). Overall, canine retraction was 1.5 times greater on the L-PRF side than on the control side. Canine rotation showed no significant relationship, whereas pain and soft tissue healing were significantly better on the L-PRF side than on the control side. Conclusions: Local administration of L-PRF amplifies canine retraction while improving pain and soft tissue repair. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. Evaluation of dentoalveolar changes following maxillary incisor intrusion with one vs two anterior miniscrews in subjects with gummy smile: a randomized clinical trial.

Author

M, Manikandan, Das, Surya Kanta, Barik, Ashish Kumar, Raj, Subash Chandra, Mishra, Mitali, Rath, Sunil Kumar, and Sah, Sushila

Subjects
CONE beam computed tomography, DENTAL arch, ROOT resorption (Teeth), DENTAL implants, WILCOXON signed-rank test, TOOTH replantation, MOUTH protectors
Published
2024
Full Text
View/download PDF

20. The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex

Author

Martínez, Jose L., primary, Lemus, Nicholas, additional, Lai, Tsoi Ying, additional, Mishra, Mitali, additional, González-Domínguez, Irene, additional, Puente-Massaguer, Eduard, additional, Loganathan, Madhumathi, additional, Francis, Benjamin, additional, Samanovic, Marie I., additional, Krammer, Florian, additional, Mulligan, Mark J., additional, Simon, Viviana, additional, Palese, Peter, additional, and Sun, Weina, additional

Published
2024
Full Text
View/download PDF

23. List of contributors

Author

Abdullah, Muhammad Faiq, primary, Amaro Bittencourt, Gustavo, additional, Arun, K.B., additional, Binod, Parameswaran, additional, de Oliveira Penha, Rafaela, additional, Farooqui, Alvina, additional, Fatehi, Pedram, additional, Gaur, Prachi, additional, Gaur, Vivek Kumar, additional, Gautam, Krishna, additional, Gie, Gan Pei, additional, Ishfaq Bhat, Mohd., additional, John, Maria Sindhura, additional, Karp, Susan Grace, additional, Kaur, Rajwinder, additional, Kley Valladares-Diestra, Kim, additional, Konduri, Mohan, additional, Kong, Fangong, additional, Kulangara, Niveditha, additional, Kumar, Lalit R., additional, Kumar, Virendra, additional, Kumlehn, Gabriel Sprotte, additional, Madhavan, Aravind, additional, Magalhães Junior, Antônio Irineudo, additional, Magdouli, Sara, additional, Manickam, Natesan, additional, Mishra, Mitali, additional, Morya, Raj, additional, Murawski de Mello, Ariane Fátima, additional, Nagoth, Joseph Amruthraj, additional, Negi, Taru, additional, Omar, Mohd Firdaus, additional, Pagnoncelli, Maria Giovana Binder, additional, Pandey, Aishwarya, additional, Pandey, Ashok, additional, Pandey, Ashutosh Kumar, additional, Pandey, Kritika, additional, Pandey, Srinath, additional, Philip, Eapen, additional, Pokhrel, Sameer, additional, Porto de Souza Vandenberghe, Luciana, additional, Prado, Fernanda, additional, Reddy, Nalla Bhanu Prakash, additional, Reshmy, R., additional, Saffar, Thana, additional, Saini, Preety, additional, Salaghi, Ayyoub, additional, Sharma, Aditi, additional, Sharma, Poonam, additional, Sindhu, Raveendran, additional, Singh, Lalit Kumar, additional, Singh, Shikhangi, additional, Sirohi, Ranjna, additional, Soccol, Carlos Ricardo, additional, Srivastava, Aditya, additional, Srivastava, Janmejai Kumar, additional, Sukumaran, Swapna Thacheril, additional, Tarafdar, Ayon, additional, Thakur, Indu Shekhar, additional, Ting, Sam Sung, additional, Tiwari, Bhagyashree, additional, Tyagi, Bhawna, additional, Tyagi, R.D., additional, Upadhyay, Sudha, additional, Vaisakh, P.H., additional, Vivek, Narisetty, additional, Wahid, Fazli, additional, Yadav, Bhoomika, additional, Yellapu, Sravan Kumar, additional, Younis, Kaiser, additional, Zhong, Cheng, additional, and Zhou, Long, additional

Published
2021
Full Text
View/download PDF

27. Microbial Interactions in Litchi Rhizosphere

Author

Vishwakarma, Kanchan, Upadhyay, Neha, Kumar, Nitin, Verma, Rishi, Singh, Jaspreet, Verma, Pankaj, Mishra, Mitali, Jain, Shruti, Tripathi, Durgesh Kumar, Mishra, Rohit Kumar, Kumar, Vivek, Sharma, Shivesh, Kumar, Manoj, editor, Kumar, Vivek, editor, Bhalla-Sarin, Neera, editor, and Varma, Ajit, editor

Published
2017
Full Text
View/download PDF

36. Efficacy and safety of degludec U100 versus glargine U300 for the early postoperative management of patients with type 2 diabetes mellitus undergoing coronary artery bypass graft surgery: A non‐inferiority randomized trial

Author

Kuchay, Mohammad Shafi, primary, Mathew, Anu, additional, Mishra, Mitali, additional, Surendran, Parvathi, additional, Kaur, Parjeet, additional, Wasir, Jasjeet Singh, additional, Gill, Harmandeep Kaur, additional, Jain, Rujul, additional, Gagneja, Sakshi, additional, Kohli, Chhavi, additional, Kumari, Poonam, additional, Singh, Manish Kumar, additional, and Mishra, Sunil Kumar, additional

Published
2022
Full Text
View/download PDF

37. LBSUN207 Efficacy And Safety Of Degludec U100 Versus Glargine U300 For The Hospital Management Of Patients With Type 2 Diabetes: A Prospective, Open-label, Non-inferiority Randomized Controlled Trial

Author

Kuchay, Mohammad Shafi, primary, Mathew, Anu, additional, Mishra, Mitali, additional, Parvathi, S, additional, Kaur, Parjeet, additional, Wasir, Jasjeet Singh, additional, Gill, Harmandeep Kaur, additional, Jain, Rujul, additional, Gagneja, Sakshi, additional, Kohli, Chhavi, additional, Kumari, Poonam, additional, Singh, Manish Kumar, additional, and Mishra, Sunil Kumar, additional

Published
2022
Full Text
View/download PDF

47. Efficacy and Safety of Degludec U100 Versus Glargine U300 for the Hospital Management of Patients with Type 2 Diabetes: A Prospective, Open-Label, Non-Inferiority Randomized Trial

Author

Kuchay, Mohammad, primary, Mathew, Anu, additional, Mishra, Mitali, additional, Parvathi, S, additional, Kaur, Parjeet, additional, Wasir, Jasjeet Singh, additional, Gill, Harmandeep Kaur, additional, Jain, Rujul, additional, Gagneja, Sakshi, additional, Kohli, Chhavi, additional, Kumari, Poonam, additional, Singh, Manish Kumar, additional, and Mishra, Sunil Kumar, additional

Published
2022
Full Text
View/download PDF

48. Efficacy and safety of degludec U100 versus glargine U300 for the early postoperative management of patients with type 2 diabetes mellitus undergoing coronary artery bypass graft surgery: A non‐inferiority randomized trial.

Author

Kuchay, Mohammad Shafi, Mathew, Anu, Mishra, Mitali, Surendran, Parvathi, Kaur, Parjeet, Wasir, Jasjeet Singh, Gill, Harmandeep Kaur, Jain, Rujul, Gagneja, Sakshi, Kohli, Chhavi, Kumari, Poonam, Singh, Manish Kumar, and Mishra, Sunil Kumar

Subjects
DRUG efficacy, CORONARY artery bypass, INSULIN derivatives, BLOOD sugar monitoring, GLYCEMIC control, POSTOPERATIVE care, SURGERY, PATIENTS, MANN Whitney U Test, FISHER exact test, TYPE 2 diabetes, RANDOMIZED controlled trials, DESCRIPTIVE statistics, HYPOGLYCEMIA, CHI-squared test, STATISTICAL hypothesis testing, STATISTICAL sampling, DATA analysis software
Abstract

Aims: To compare the efficacy and safety of degludec U100 versus glargine U300 for the early postoperative management of patients with type 2 diabetes mellitus (T2D) undergoing coronary artery bypass graft (CABG) surgery. Methods: A total of 239 patients were randomly assigned (1:1) to receive a basal‐bolus regimen in the early postoperative period using degludec U100 (n = 122) or glargine U300 (n = 117) as basal and glulisine before meals. The primary outcome was mean differences between groups in their daily BG concentrations. The major safety outcome was the occurrence of hypoglycemia. Results: There were no differences in mean daily BG concentrations (157 vs. 162 mg/dl), mean percentage of readings within target BG of 70–180 mg/dl (74% vs. 73%), daily basal insulin dose (19 vs. 21 units/day), length of stay (median [IQR]: 9 vs. 9 days), or hospital complications (21.3% vs. 21.4%) between treatment groups. There were no differences in the proportion of patients with BG <70 mg/dl (15.6% vs. 23.1%) or <54 mg/dl (1.6% vs. 4.3%) between degludec‐100 and glargine‐300 groups. Conclusions: Treatment with degludec U100 is as effective and safe as glargine U300 for the early postoperative hospital management of patients with T2D undergoing CABG. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results